Multimodal Assesment of Alzheimer Patients
NCT06448403
Summary
The goal of this study is to learn more about the changes in the brains of patients with cognitive impairment (MCI) and Alzheimer's Disease (AD). The main questions the study aims to answer are: 1. What findings can be used to earlier detect patients that will develop Alzheimers? 2. Which differences are seen between healthy and cognitively impaired patients? 3. Which differences are seen between patients with Alzheimers disease? Participants will undergo: * Cognitive tests * Magnetic resonance imaging (MRI) * Electroencephalography (EEG) * Blood sample collection * Fecal sample collection * A randomized group will undergo polysomnography analysis.
Eligibility
Inclusion Criteria: * MCI and AD according to relevant ICD-criterias. * Control cohort is age and gender matched with other cohorts. Exclusion Criteria: * Uneligibility for any of the planned neuroimagery devices (MRI, EEG) * AD diagnosis before the age of 65 (Early-onset AD). * Brain tumor * Traumtic head injury * Earlier neurosurgery * Other neyrodegenerative diseases (i.e Parkinson and ALS) * Diseases related to inflammation and auto-immunity (i.e MS)
Conditions5
Interventions2
Related trials
- Cancer of the Lung And SeneScencE - Prospective Cohort 1 — Assistance Publique - Hôpitaux de Paris
- Cardiovascular Outcome of Cancer Patients: The "GMEDICO Cohort" — Assistance Publique Hopitaux De Marseille
- Evaluation of the Effectiveness of Platelet-based and Microvesicle-based Assays to Predict Thrombotic and Bleeding Risk in Chronic Kidney Disease Patients With Acute Coronary Syndrome — Assistance Publique Hopitaux De Marseille
- Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate Cancer — Centre Jean Perrin
- LIQUID BIOPSY IN Low-grade Glioma Patients — University Hospital, Montpellier
- Memory Deterioration in Alzheimer Disease — Norwegian University of Science and Technology
- Molecular Analysis of Endoscopic Cytology Samples Supernatant in Pulmonary Nodules — University Hospital, Toulouse
- Study of High Density Lipoprotein Function in Type 1 Diabetic Patients With Nephropathy — Centre Hospitalier Universitaire Dijon
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06448403